MENU
ANVS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Annovis Bio (ANVS) Earnings Date & Reports
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States... Show more
A.I. Advisor
published Earnings
ANVS is expected to report earnings to fall 7.28% to -37 cents per share on November 11
Q3'26
Est.
$-0.37
Q2'26
Beat
by $0.06
Q1'26
Missed
by $0.23
Q4'25
Missed
by $0.05
Q3'25
Missed
by $0.06
The last earnings report on August 14 showed earnings per share of -40 cents, beating the estimate of -46 cents. With 357.32K shares outstanding, the current market capitalization sits at 58.90M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders
Industry Biotechnology
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
8
Web
https://www.annovisbio.com